Nanomedicine is emerging as effective therapeutic strategy for cancer therapy. In addition, cancer nanomedicine is at the interface of several diverse fields and this, taken together with the complexities of nanomedicine and cancer, requires a multidisciplinary effort to advance the understanding and development of cancer-specific nanomedicine in order to meet the current challenges in translating nanomedicine into the clinic. In article number 1700432 Vimalkumar Balasubramanian, Hélder A. Santos, and co-workers review nanomedicine for cancer therapy.
http://ift.tt/2FnKFTS
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.